| MRC News - September 2004 |
|
Bug war
MRC scientists have recently discovered that a significant proportion of pneumonia in children is not caused by a virus, but by a bacterium - the pneumococcus. This has important implications for the treatment of children.
World Health Organisation statistics state pneumonia as the leading cause of death in children worldwide. Almost four million children die of the disease each year - most of them in developing countries.
Almost a year ago, scientists from the MRC's Respiratory and Meningeal Pathogens Research Unit proved that a 9-valent pneumococcal vaccine significantly reduced pneumonia, pneumococcal disease and antibiotic-resistant pneumococcal disease among forty thousand infant trial participants in Soweto. An added bonus was that the vaccine also showed promise in the treatment of HIV-positive infants.
Now further analysis of trial results has shown that 31% of children's pneumonias, previously thought to be caused only by viruses, are in fact caused by a bacterium. This was proved by the fact that the pneumococcal vaccine prevented viral-associated pneumonia in the children.
According to Prof Keith Klugman, the director of the unit, the findings are important for a number of reasons. "They show that children in hospital with severe pneumonia need antibiotics."
A viral illness (such as a cold or flu) is not treated with antibiotics; this medication is only effective for a bacterial infection. The reason is that antibiotics target the cell wall and metabolism of bacteria, and a virus does not have a cell wall. Since viruses also have different metabolic pathways to bacteria, antibiotics are completely ineffective.
"Up until now, the emphasis has been to try and find out whether the infection was caused by a virus or a bacterium before starting treatment. But this shows that by the time a child reaches hospital, the virus and the bacterium are working together, so treatment with an antibiotic will be effective."
The results have been very encouraging: Prof Klugman says the vaccine is better at preventing pneumonia than was previously thought.
The results also show the extent of the collaboration between viruses and bacteria in causing human illness. "Our evidence shows that what starts out as a viral infection often ends in a bacterial infection. We think that between one third and one half of all viral pneumonia infections are actually caused by the pneumococcus bacterium. The results show that the vaccine reduces pneumonia associated with respiratory viral infections, because it prevents the bacterium from infecting a child who might already be struggling with a viral infection."
What causes pneumococcal disease?
Pneumococcal disease is an infection caused by a type of bacteria called Streptococcus pneumoniae. When these bacteria invade the lungs, they cause the most common kind of bacterial pneumonia. The bacteria can also invade the bloodstream (causing bacteremia) and even the tissues and fluids surrounding the brain and the spinal cord, causing meningitis.
How does pneumococcal disease spread?
The disease is spread from person to person by droplets in the air. Many people carry the bacteria in their nose and throat without ever developing invasive disease.
What are the symptoms?
The symptoms of pneumococcal pneumonia include high fever, cough with the production of mucus, shaking chills, breathlessness, as well as chest pain that increases with breathing and coughing. The symptoms of pneumococcal meningitis include stiff neck, fever, mental confusion and disorientation, as well as photophobia (visual sensitivity to light). The symptoms of pneumococcal bacteremia may include a combination of the symptoms of pneumonia and meningitis, along with arthritis and fever.
Why a 9-valent pneumococcal vaccine?
There are around ninety different types of pneumococcal bacteria. What distinguishes these bacteria from one another is that each is surrounded by a different type of sugar (carbohydrate) capsule.
The body's immune system encounters the sugar capsule first. If it is able to recognize that particular capsule, it can spring into action and eliminate the bacteria. Pneumococcus vaccines contain harmless versions of these capsules, which the body then learns to recognize and attack.
The 9-valent pneumococcal vaccine contain the capsules that surround the nine most important types of pneumococcal bacteria that are responsible for causing disease in children.
There a licensed vaccine in the United States with seven capsule types in it. But the 9-valent vaccine has two additional types (called types 1 and 5) that are common in Africa and in developing countries.
Sources: National Foundation for Infectious Diseases, www.nfi.org, the Immunization Action Coalition, www.vaccineinformation.org, and Prof Keith Klugman. |
For more information, contact Prof Klugman at (011) 489-9330.
|
|